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Abstract: Plasmodium berghei is the rodent
equivalent of Plasmodium falciparum which
causes cerebral malaria in humans. However,
P. berghei does not cause cerebral malaria in
BALB/c mice, instead it leads to parasitemia,
fever and some degree of liver damage.
Although different aspects of immunological
response have been intensively investigated in
malaria; this the first time the in vitro effect
of P. berghei antigen lysate on murine NK
cytotoxic activity was studied. It was
observed that this parasite antigen lysate
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Introduction
Malaria is still one of the major public health problems
because of its important morbidity and mortality, and
cerebral malaria is the most life-threatening complication
(1). South–East Asia cerebral malaria (CM) is
accompanied by severe pathology in different organs
whereas other organ pathology is usually absent in
African children with cerebral malaria (2). While CM is
often a fatal complication of human Plasmodium
falciparum infection, its pathophysiology remains poorly
understood (3). The lack of suitable animal model has
hampered the progress in the understanding of the
human disease process. Nevertheless, a mouse model,
despite the numerous differences reviewed by White and
Ho in 1992 (3) has allowed the recognition of critical
factors which help specifying some steps of human CM
(4). TNF plays a pivotal role. It is uncertain what mediates
protection against malaria in human, but certain MHC
molecules (5) and anti–resetting antibodies (6) have both
been associated with protection against severe malaria
while antibodies reactive to several different antigens
(7–10) and T cell reactivity to merozoite surface protein
(10) have been associated with protection against clinical
disease.

suppresed the cytolytic activity of NK cells in
a dose–dependent manner. Because the
suppression of NK cell activity in a
dose–dependent manner by P. berghei
antigen lysate is not in harmony with the fact
that BALB/c mice is resistant to cerebral
malaria caused by this parasite in other
rodents, we concluded thet NK cell activity
may not play a major role in this resistance.
Key Words: Natural killer (NK)
cytotoxicity, Plasmodium berghei.

cell,

Plasmodium berghei is the equivalent of P. falciparum
of humans in the rodents. Plasmodium berghei is malaria
strain causing cerebral malaria in different mice strains,
for example CBA/J mice, but not in BALB/c mice. This
parasite mainly causes parasitemia, anemia, fever and
some degree of liver demage in BALB/c mice (11).
Monouclear phagocytes from CBA/J, the CM–susceptible
mouse, have been shown to produce more nitric oxide
than those of BALB/c, the CM–resistant mouse, after
stimulation by IFN–γ and TNF–α, two critical cytokines in
mouse CM (11). In the P. berghei ANKA infections,
cerebral pathology is the only pathology found and it can
be prevented by treatment with antibody against TNF
(12) or by suppression of monocytopoiesis (13).
Activation of the immune system in malaria plays an
important role in both defense against parasites and
pathogenesis. Thus, in murine malaria, T cells mediate
protection against infection (14), and yet contribute to
the development of CM in P. berghei–infected CBA mice
(15).
Protective immunity to P. berghei can be obtained by
vaccination of mice with irradiated sporozoites injected by
intravenous route. This immunity has several unique
features; it is stage–specific and species–specific but it is
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not strain–specific. Above all it is very strong, sterile type
of immunity that enables the animals to resist very high
challenge doses (16). Cerebral symptoms in a murine
malaria infection (P. berghei) can be blocked by antibodies
against TNF. However, in another model, using different
strains of same parasite and a different mouse strain, this
result cannot be reproduced (17).
As a part of immune system, the role of natural killer
(NK) cells in plasmodial infections has been investigated
by various scientists. Eugui and Allison reported that
mouse strain resistant to Plasmodium chabaudi infection
showed high NK cell activities whereas other scientists
reported that there was no relationship between NK
activity and protection against P. chabaudi infection using
NK cell deficient mice (18, 19). There are, however, some
findings suggesting that NK cells play certain roles in
protection against plasmodial infection: Cytotoxicity of
human NK cells to schizonts of P. falciparum (20), natural
cytotoxicity of rat spleen cells to P. berghei–parasitized
erythrocytes (21) and possible relevance of IFN and NK
celly system in P. falcipuram infection (22).
In this study, we aimed to show the in vitro effects of
P. berghei on NK cell activity of splenocytes of BALB/c
mice which have been known to be CM–resistant; this
could help to explain, at least in part, why this strain of
mouse can be infected by this parasite, but dose not
develop CM contrary to most of other rodents.
Materials and Methods
Mice: We used 4 female BALB/c mice (purchased from
Harlan) for preparation of antigen lysate, 6 male BALB/c
mice in the first set of experiments and 5 BALB/c mice (3
males, and 2 females) in the second set of experiments.
All mice were six to eight weeks old and healthy.
Parasite: Plasmodium berghei ANKA 6653 strain was
provided by Kemal Çeber from the Institute of
Parasitology, Baku, Azerbeycan.
Plasmodium berghei antigen lysate: The P.
berghei–infected erythrocytes had been frozen–stroed in
liquid nitrogen. After these erythrocytes were thawed and
washed twice with 0.9% NaCl solution (saline), they were
administered to 4 female BALB/c mice intraperitoneally.
Nine days later, mice were anesthetized with ketamine at
80 mg/kg. After opening their thoracal cavities, 1 ml of
blood was drawn from heart of each mouse into a
heparinized syringe (50 µl liquemin). Heparinized blood
was diluted with an equal volume of saline. After diluted
blood
is
layered
on
3ml
Ficoll–Hypaque
(Histopaque–1077, Sigma), it was centrifuged at 1500
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rpm for 30 minutes. Under these conditions most of the
infected erythrocytes suspended in mononuclear cell
containing bufy coat. Buffy coats containing infected
eryhocytes were collected, pooled and centrifuged. After
washing the pellet with saline solution for 3 times,
supernatant was discarded, and 8 ml of pyrogen–free
distilled water was added onto the pellet. It was
resuspended and left at room temperature for 20
minutes, and then ultracentrifuged at 4oC at 39.000 rpm
for 30 minutes using Sorvall TST 60.4 rotor (OTD
Combi, Sorvall Ultracentrifuge, Du Pont Company,
Wilmington Delware 19898, USA). Supernatant was
discarded and 6 ml of pyrogen–free distilled water was
added onto the pellet. Sonic oscillation (Vibra Cell, VC
100 Ultrasonic processer, Sonics & Material Inc.
Connecticut, USA) was applied to completely disperse the
parasite antigen lysate. After sonification, antigen lysate
was lyophilized (Vitris Benchtop 3L, Vitris Company, Inc.
Gardiner, NY 12525, USA). In the experiments, this
lyophilized antigen lysate was weighed, and desired
concentrations of antigen solution was prepared by
adding RPMI–1640 (Sigma Chemical Co., St. Louis, Ma.,
USA). Antigen solutions were filtered with 0.2 µm filters
(Costar) before usage. After making preliminary
experiments, final antigen concentrations were adjusted
to desired levels between 25–200 µg/ml, and 0.3–30
µg/ml for the first and the second sets of experiments
respectively.
Effector cells: Effector cells were isolated from the
spleens of BALB/c mice. BALB/C mice were killed by
cervical dislocation and splenectomy was performed with
a lateral incision. Each spleen was teased in 5 ml 0.9%
NaCl in a small plastic petri–dish and homogenized by
flushing up and down several times with a syringe. The
spleen cell suspension was layered onto 3 ml of
Histopaque (Sigma) and then centrifuged at 1500 rpm
for 30 minutes. Buffy coat was collected with a Pasteur
pipette and washed twice with 0.9% NaCl. The pellets
were resuspended in 4 ml of RPMI–1640 medium
(Sigma) with 5% inactivated Fetal Calf Serum (FCS,
Biochrome). Then the cell suspension was transferred
into 3x10 mm cell–culture treated plastic petri–dish
(Greiner) and incubated in a humidified atmosphere of
5% CO2 at 37oC for 30 minutes. This provided the
monocytes to adhere the plastic surface. After the
incubation, non–adherent cells were harvested and
washed once with 0.9% NaCl. The pellet was throughly
resuspended in RPMI–1640 supplemented with 10%
FCS. Viability of the effector cells was >97% by trypan
blue dye exclusion. Effector cell concentrations were
adjusted to 1x106 cells/ml in RPMI–1640 with 10% FCS.
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Target cells: YAC–1 cell line was maintained in
RPMI–1640 supplemented with 0.3 gr/lt L–Glutamine
and 10% inactivated FCS in a humidified atmosphere of
5% CO2 at 37oC. Target cell viability was always higher
than 90% in each of the experiments.

Cytotoxicity was calculated from the average counts
per minute (cpm) released into the supernatants of
triplicate samples by the following formula:

NK Cytotoxicity Assay: In order to determine natural
killer (NK) cell cytotoxic activity, Chromium–51 release
assay was used with some modifications of that described
elsewhere (23). Briefly, YAC–1 cells were lebeled by
incubating 2–3x106 cells with 200 µCi of sodium
chromate (51Cr) (CJ51, Amersham, UK) for 1 hour at
37oC, pelleted, washed twice with 10 ml of RPMI–1640
and resuspended at the concentration of 1x105 cells/ml.
Control cytotoxicity at Effector: Target ratios (E/T) used
were 100/1, 50/1, and 25/1 in wells of U–bottomed
96–well microtiter plates. The effect of P. berghei antigen
lysate on NK cytotoxic activity was compared to control at
E/T: 50/1. Each E:T ratios was studied in triplicate.
Antigen suspensions were prepared at 1000, 500, 250
and 125 µg/ml for the first set of experiments and 150,
50, 15, 5 and 1.5 µg/ml for the second set of
experiments and 50 µl of each antigen suspension was
added upon 100 µl of effector cells in appropriate wells
15 min before adding 100 µl of target cells (1x104 cells).
Thus, final antigen concentrations during the assay period
became 200, 100, 50 and 25 µg/ml for the first set of
experiments and 30, 10, 3, 1 and 0,3 µg/ml (in wells) for
the second set of experiments. Microtiter plates were
incubated at 37oC for 4 hours. After incubation, the
plates were centrifuged at 600 rpm for 6 minutes and
125 µl of supernatant from each well was taken and
counted by a gamma counter (LKB 1275, Minigamma
counter).

Statistical method: The student’s t–test was used in
order to make statistical analysis of differences.

In order to determine the spontaneous release
(control), target cells were incubated with 150 µl medium
only. Maximum release was obtained by incubating target
cells with 150 µl of 2% sodium dodecyl sulfate.

% specific cytolysis= (sample cpm–spontaneous cpm)
/ (maximum cpm–spontaneous cpm) x 100

Results
P. berghei antigen lysate was found to suppress NK
cell cytotoxic activity in vitro. In the preliminary
experiments the effect of P. berghei antigen lysate on NK
cell activity was investigated at the final concentrations
from 25 to 200 µg/ml. These antigen concentrations
were found to be too high to make a decision about the
breakpoint effect on NK cytotoxic activity (Table 1).
Therefore, we later adjusted the desired final antigen
concentrations between 0.3 and 30 µg/ml. That time, as
shown in Figure 1, it was observed that P. berghei
antigen lysate suppressed the cytolytic activity of NK cells
in a dose dependent manner (p= 0.044 for 3 µg/ml vs
control, p=0.0102 for 10 ug/ml vs control, p=0.00478
for 30 µg/ml vs control).
Discussion
Malaria is still a very important public health problem
because of its dangerous complications like cerebral
malaria caused by P. falciparum in humans (1). P. berghei
is the equivalent of P. falciparum of humans in the
rodents; however, this species does not cause cerebral
malaria in BALB/c mice, instead it causes parasitemia,
anemia, fever and some liver damege (11). Many
immunologic aspects of P. berghei infection has been
intensively studied in different types of rodents; however,

Table 1.

Final concetrations of Plasmodium berghei antigen lysate (µg/ml)
Mouse
a

0

25

50

100

200

28.74*

14.26

16.33

16.39

17.14

b

31.81

16.27

20.60

22.29

21.83

c

27.03

16.93

20.90

23.25

22.17

d

16.10

9.35

10.11

11.90

13.27

e

27.02

12.11

16.89

15.68

16.91

f

13.26

6.23

8.40

9.32

10.07

Effect of Plasmodium
berghei antigen Iysate on
NK cytotoxic activity at the
concentrations of 25–200
µg/ml.

* % Cytotoxicity.
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Figure 1.

the effect o fthis parasite on the NK activity of
splenocytes of BALB/c mice has not been investigated.
Natural killer cells comprise 4 to 15% of the
mononuclear cells in the peripheral circulation, and have
important roles in the immune responses against tumors
and viral infections as well as inducing production of
different cytokines like IFN–γ (24). The role of NK cells in
the protection against plasmodial infections has remained
unclear.
It was reported that mouse strains resistant to P.
chaubaudi infection showed high NK activity by Eugi, et
al. (16), but two other groups of workers suggested that
there was no relationship between NK cell activity and
protection against P. chaubaudi infection using NK
cell–deficient mice (18, 19).
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Effect of P. berghei antigen
Iysate on NK cytotoxic activity
at various concentrations.
Antigen was present with the
effector and target cells
during the assay period. NK
cytotoxic
activity
was
suppressed with antigen in a
dose dependent manner (p=
0.0201, r= –0.8819).
Asterisks denotes significant
differences (P<0.05) when
compared to control (0). Data
are the mean±SEM of five
independent experiments.

Augmentation of NK activity by administration of
MgCl2 failed to protect mice against P. yoelii infection
(25). In the experiments performed with bg/bg mutated
mice, which were shown to have reduced NK activity
(26), it was concluded that the level of NK activity was
not related to host resistance to malaria because these
mice could resolve P. chaubaudi infection (19).
NK cells are thought to have non–specific immunity
and not to be involved in immunological memory (21).
Solomon et al. reported an earlier onset of parasitemia
and earlier death in NK cell–deficient mice with P. berghei
compared to normal mice (27). Adoptive transfer of NK
cells from infected mice seemed to give no protection
except for a sliht delay in the onset of infected
erythrocytes; that is, naive mice should have sufficient
amounts of NK cells and they do not need adoptive
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transfer of an excess NK cells to protect them against
infection. However, when NK cells were depleted in vivo
by monoclonal antibodyl treatment, mortality increased
more than twice compared to controls. Therefore,
Kitaguchi et al. thought that NK cells might not prevent
mice from increasing parasitemia, but these cytotoxic cells
might play an important role in recovery from
parasitemia, probably by secreting IFN–γ and might
finally decrease the mortality in P. chaubaudi infection
(28). Stevenson and his coworkers showed that IL–12
protected mice against blood stage P. chaubaudi infection
(29); therefore, NK cells may contribute to protection
against plasmodial infections in the early phase through
their activation by IL–12 and sequential secretion of
IFN–γ (28).
In our first set of experiments, we had used 25–200
µg/ml P. berghei ANKA 6653 antigen lysate; however,
these concentrations were too high to make any
statistically significant comparison between the
spontaneous NK activity and stimulation by antigen.
Therefore, in our second set of experiments we decided
to lower our antigen doses and repeated our study. This
time we used 0.3–30 µg/ml P. berghei antigen lysate, and
it was observed that cytolytic activity of mice splenocytes
was suppressed significantly with increasing doses of
parasite antigen (Figure 1). Nevertheless, we have to
decrease the antigen doses to much lower values to see
where the suppression ceases. With this purpose we

performed some prologue studies with antigen doses of
0.01 µg/ml, 0.03 µg/ml and 0.1 µg/ml in 2 BALB/c mice
(data not shown) and saw that suppression of NK activity
was overcome when dose was decreased to 0.03 µg/ml in
one mouse and to 0.01 µg/ml in the other one.
Consequently, we need a large number of experiments
with lower doses of P. berghei antigen lysate in order to
determine the dose limits acting on NK activity.
NK cells are important cytotoxic cells of immune
system, especially effective on tumor cells and virally
infected cells. Their role in various parasitic diseases are
also under investigation. Parasites which act specifically
on spleen, like malaria, might be affected by these cells
which are rich in spleen. Eugui et al. investigated the
differences in susceptibility of various mouse strains to
haemoprotozoan infections and though about the possible
correlation with NK activity (30). Although we found out
that P. berghei antigen lysate suppressed the NK activity
in BALB/c mice, we know that this parasite does not cause
cerebral malaria in this mouse strain. However, this does
not mean that the parasite does not cause any problem;
it causes some parasitemia, etc. (11). This may be
explained by the parasite burden; the amount of parasite
entering the body may be enough to cause an infection
together with NK suppression; however, it may still not
be enough to challenge with all other compartments of
immunological system in order to cause cerebral malaria.
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